The vagus nerve and the nicotinic anti-inflammatory pathway
- PMID: 16056392
- DOI: 10.1038/nrd1797
The vagus nerve and the nicotinic anti-inflammatory pathway
Abstract
Physiological anti-inflammatory mechanisms are selected by evolution to effectively control the immune system and can be exploited for the treatment of inflammatory disorders. Recent studies indicate that the vagus nerve (which is the longest of the cranial nerves and innervates most of the peripheral organs) can modulate the immune response and control inflammation through a 'nicotinic anti-inflammatory pathway' dependent on the alpha7-nicotinic acetylcholine receptor (alpha7nAChR). Nicotine has been used in clinical trials for the treatment of ulcerative colitis, but its clinical applications are limited by its unspecific effects and subsequent toxicity. This article reviews recent advances supporting the therapeutic potential of selective nicotinic agonists in several diseases. Similar to the development of alpha- and beta-agonists for adrenoceptors, selective agonists for alpha7nAChR could represent a promising pharmacological strategy against infectious and inflammatory diseases.
Similar articles
-
The neuronal strategy for inflammation.Novartis Found Symp. 2007;280:223-33; discussion 233-7. Novartis Found Symp. 2007. PMID: 17380797 Review.
-
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation.Br J Pharmacol. 2007 Aug;151(7):915-29. doi: 10.1038/sj.bjp.0707264. Epub 2007 May 14. Br J Pharmacol. 2007. PMID: 17502850 Free PMC article. Review.
-
The vagus nerve as a modulator of intestinal inflammation.Neurogastroenterol Motil. 2009 Jan;21(1):6-17. doi: 10.1111/j.1365-2982.2008.01252.x. Neurogastroenterol Motil. 2009. PMID: 19140954 Review.
-
GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation.Biochem Pharmacol. 2009 Oct 1;78(7):863-72. doi: 10.1016/j.bcp.2009.06.096. Epub 2009 Jul 1. Biochem Pharmacol. 2009. PMID: 19576181
-
Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.Nature. 2003 Jan 23;421(6921):384-8. doi: 10.1038/nature01339. Epub 2002 Dec 22. Nature. 2003. PMID: 12508119
Cited by
-
Known drugs and small molecules in the battle for COVID-19 treatment.Genes Dis. 2020 Dec;7(4):528-534. doi: 10.1016/j.gendis.2020.06.007. Epub 2020 Jun 20. Genes Dis. 2020. PMID: 32837982 Free PMC article. Review.
-
Modulation of innate immune-related pathways in nicotine-treated SH-SY5Y cells.Amino Acids. 2012 Sep;43(3):1157-69. doi: 10.1007/s00726-011-1171-0. Epub 2011 Dec 21. Amino Acids. 2012. PMID: 22187147 Free PMC article.
-
COVID-19 infection and cardiac arrhythmias.Trends Cardiovasc Med. 2020 Nov;30(8):451-460. doi: 10.1016/j.tcm.2020.08.002. Epub 2020 Aug 16. Trends Cardiovasc Med. 2020. PMID: 32814095 Free PMC article. Review.
-
Auto/paracrine control of inflammatory cytokines by acetylcholine in macrophage-like U937 cells through nicotinic receptors.Int Immunopharmacol. 2010 Mar;10(3):308-15. doi: 10.1016/j.intimp.2009.12.001. Epub 2009 Dec 18. Int Immunopharmacol. 2010. PMID: 20004742 Free PMC article.
-
Prevalence and patterns of symptoms of dysautonomia in patients with long-COVID syndrome: A cross-sectional study.Ann Clin Transl Neurol. 2022 Jun;9(6):778-785. doi: 10.1002/acn3.51557. Epub 2022 Apr 8. Ann Clin Transl Neurol. 2022. PMID: 35393771 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
